TLRY

Conviction 18HealthcareScan · Mon, Aug 10, 2026

TLRY$4.42-3.39%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 5.68M

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest +100.00%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Tilray Brands, Inc.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.tilray.com ↗

Price4.42

Change-3.39%

Gap-1.09%

Rel volume1.27×

Avg volume4.95M

Avg $ vol21.16M

SMA 204.29

SMA 504.59

SMA 2005.94

Price vs 50-3.82%

Price vs 200-25.64%

MA stackbearish

50/200 cross—

Supertrendup · 4.00

RSI (14)50

MACD hist0.06

MACD crossbull · 7d

Stoch %K / %D59 / 63

ADX (14)20

+DI / −DI24 / 27

RSI divergence—

MACD divergence—

ATR %+5.52%

ADR %5.06%

52w high13.94

52w low0.6487

From 52w high-68.33%

Above 52w low+580.59%

New 52w highNo

SqueezeOff

Bollinger width20.60%

%B0.64

Donchian pos58.66%

Donchian high4.94

Donchian low3.67

AVWAP (52w high)7.46

vs AVWAP high-40.81%

AVWAP (52w low)2.40

vs AVWAP low+83.62%

OBV trendFlat

Chaikin MF (20)0.03

Today vs 20d1.27×

Avg vol (14d)5.68M

Avg vol (20d)4.95M

Avg $ vol (20d)21.16M

Market cap—

RS 3m (vs SPY)-24.96%

RS 6m (vs SPY)-49.29%

RS line new highNo

Trend template3/8

Technical rank16.6

1 week-4.85%

1 month-0.11%

3 months-20.59%

6 months-41.75%

1 year+578.71%

YTD-54.58%

P/E-5.14

P/B0.39

P/S0.68

P/FCF-5.48

EPS-1.09

Div yield—

ROE-7.52%

ROA-5.21%

Debt/Eq0.11

Current2.21

EV/EBITDA6.33

Gross margin28.45%

Net margin-13.26%

Rev growth11.46%

EPS growth94.45%

Price target6.13

Target upside33.84%

Analyst ratingHold

Institutional9.19%

Ent. value579.81M

Revenue206.73M

Net income-26.57M

Gross profit54.95M

Free cash flow-113.79M

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out119.6M

Employees2.84K

ListedFri, Jan 23, 2015

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank16.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.90

Support3.74

Days since event—

Candle confirm—

News sentiment—

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TLRY

All disclosures →

No recent disclosed trades by Congress in TLRY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TLRY · 1 buy · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Gendel Mitchell Global General Counsel · Common Stock · 2026-08-06	Buy	2.5K	$11K	2026-08-06	2026-08-07
Hopkinson David G. Director · Common Stock · 2026-04-21	Sell	33.56K	$233K	2026-04-21	2026-04-22

SEC filings

EDGAR filings in TLRY · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.